Stockreport

Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference [Yahoo! Finance]

Cytek Biosciences, Inc.  (CTKB) 
PDF demand and strong adoption from both pharmaceutical and academic customers since its CYTO launch. Recurring revenue rose to 34% of sales (from 29%) as service and reag [Read more]